Bright Minds Biosciences (XCNQ:DRUG) Operating Cash Flow per Share : C$-1.37 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Bright Minds Biosciences Operating Cash Flow per Share?

Bright Minds Biosciences's operating cash flow per share for the three months ended in Dec. 2023 was C$-0.21. Bright Minds Biosciences's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-1.37.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -103.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Bright Minds Biosciences's Operating Cash Flow per Share or its related term are showing as below:

XCNQ:DRUG' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -103.2 Med: -103.2 Max: -103.2
Current: -103.2

During the past 4 years, Bright Minds Biosciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was -103.20% per year. The lowest was -103.20% per year. And the median was -103.20% per year.

XCNQ:DRUG's 3-Year OCF Growth Rate is ranked worse than
95.97% of 1242 companies
in the Biotechnology industry
Industry Median: 3.6 vs XCNQ:DRUG: -103.20

Bright Minds Biosciences Operating Cash Flow per Share Historical Data

The historical data trend for Bright Minds Biosciences's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Minds Biosciences Operating Cash Flow per Share Chart

Bright Minds Biosciences Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Operating Cash Flow per Share

-0.23

-4.08

-5.50

-1.89

Bright Minds Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial												-0.74	-0.40	-0.44	-0.32	-0.21

Competitive Comparison of Bright Minds Biosciences's Operating Cash Flow per Share

For the Biotechnology subindustry, Bright Minds Biosciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bright Minds Biosciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bright Minds Biosciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bright Minds Biosciences's Price-to-Operating-Cash-Flow falls into.

Bright Minds Biosciences Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Bright Minds Biosciences's Operating Cash Flow per Share for the fiscal year that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (A: Sep. 2023 )	=	Cash Flow from Operations (A: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (A: Sep. 2023 )
	=	-7.024	/	3.720
	=	-1.89

Bright Minds Biosciences's Operating Cash Flow per Share for the quarter that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-0.822	/	3.843
	=	-0.21

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.37

Bright Minds Biosciences Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Bright Minds Biosciences's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Bright Minds Biosciences (XCNQ:DRUG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bright Minds Biosciences Inc (XCNQ:DRUG) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

DRUG:USA

Address

19 Vestry Street, New York, NY, USA, 10013

Website

https://www.brightmindsbio.com

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.